We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
In today’s manufacturing processes, defects such as loose and embedded foreign matter may cause end of line rejects of drug products—potentially leading to a loss of product or even market recalls. At the same time, regulatory authorities are becoming increasingly more stringent and continually lowering acceptable levels of particulate matter.
The West Envision™ verification system can help with both of these challenges, as it enhances the quality of Westar® ready-to-sterilize pharmaceutical components by significantly reducing adhered and embedded particulate found in primary pharmaceutical packaging components. Envision verification is also a tool to effectively reduce cosmetic defects that are of special concern in some markets like Japan. Furthermore, if a customer has special concerns, West can complete a standard defect library to catalogue findings.
The West Envision verification system uses automatic, program-controlled vision inspection technology to inspect all surfaces of elastomeric components. Envision inspected products assist in reducing the total cost of goods by minimizing the risk of drug product rejection because of visible particulates and closure defects.
Compared to other inspection methods, Envision verification allows for 100% inspection of all articles from solid to complex deep cavities passing through the machine. Therefore, you can be assured that every Envision inspected item packed for delivery to your facility meets enhanced quality specifications by statistical means.
West Envision components help reduce lot-to-lot variability in stoppers and syringe plungers. This leads to increased product yield, because the number of drug product rejects is minimized. Ultimately, the customer’s operational efficiency increases because of optimized throughput.
The West Envision verification system is an optional tool that can be used with Westar RS and Westar RU quality, and is an inherent part of West’s NovaPure® components.
West’s Graham Reynolds will present “An Integrated Approach to Biologic Drug Delivery Systems: Meeting the needs of the patient, and optimizing drug product performance,” at the Drug Delivery Partnerships meeting in Las Vegas, on January 25, 2012.
Cell-based therapies are a unique solution to a variety of health issues, and can make an undeniable impact on a person’s life. But with this unique solution comes several challenges, including packaging issues associated with cryogenic storage, inspection, and extraction of the drug product. Selecting the right packaging for the cell line can mitigate risks of breakage and cell death, enhance your ability to conduct crucial stability and integrity testing, and enable ease of transition during each phase of development.
<p><em>West is pleased to welcome guest blogger Dr. Marla Phillips, Director</em><em>, Xavier University.</em></p><p>Materials and products used to serve the drug and device industries are supplied from areas all over the world. From raw materials such as sand to highly processed components for delivery systems, the materials that are used to create packaging systems are presumed to be safe. But how can pharmaceutical manufacturers be sure that incoming materials used in these products are consistently safe and reliable?</p>
Barriers are very important for drug packaging systems. There are two roles demanded of a barrier. The first is to protect drug products from the environment. This is the primary function of a drug container closure system. The second is to prevent drug products from interacting with the packaging materials themselves. Elastomer closure manufacturers have been working to improve these barriers through multiple technologies. The technologies used on commercial products are traditional coating, and film lamination. Each has pros and cons.
West is proud to announce that we have published our 2021 Corporate Responsibility (CR) Report, Purpose. Driven., which is now available on <a href="/zh-cn/about-west/corporate-responsibility">West’s website.</a> <br />This is West’s 6<sup>th</sup> annual CR Report, and highlights ESG successes from over the past year, including progress on environmental sustainability goals, diversity and inclusion, and success around the Company’s philanthropic efforts. The publication also highlights some of the recognition received for our ESG (Environmental, Social, Governance) performance, including placement in Barron’s Top 100 Most Sustainable Companies, Corporate Social Responsibility Programme of the Year from Pharma Industry Awards in Ireland, and a Silver Stevie Award for Corporate Social Responsibility.
English
Chinese
